Levothyroxine Sodium Tablet
Product Images NDC 82804-246

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Levothyroxine Sodium (NDC 82804-246). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image-1 (94052e3d 58b2 4f4b 8223 A47281c1a592 01)

FDA Label Image

Trade Mark (94052e3d 58b2 4f4b 8223 A47281c1a592 02)

Trade Mark (94052e3d 58b2 4f4b 8223 A47281c1a592 02)
This text mentions that "LUPIN" and "the" are registered trademarks of Lupin Pharmaceuticals, Inc.*
FDA Label Image

82804-246-30 (Image 01)

82804-246-30 (Image 01)
This is a medication description of Levothyroxine Sodium 125mcg tablets, each containing 0.125mg of the active ingredient. The tablets are tan-colored, round, scored, and imprinted with "L22" on one side and a break-line on the other. The product is manufactured by Lupin Limited in India and distributed by Proficient Rx LP in Thousand Oaks, CA. It comes in a pack of 30 tablets with specific lot and serial numbers for tracking. Remember to store the medication at 25°C, out of reach of children.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.